ライフサイエンスコーパス: femoral

1 based on access site adopted (radial versus femoral).

2 oodstream infection risk, when compared with femoral.

3 ipants with carotid (5% to 50%; P=0.001) and femoral (0% to 12%; P=0.13) artery plaques and extraskel

4 atio (Spearman's r abdomen -0.986, p<0.0001; femoral -0.928, p=0.008).

5 ents compared with 486 (11.7%) patients with femoral access (0.83, 95% CI 0.73-0.96; p=0.0092).

6 v) was significantly higher with radial than femoral access (41 muSv; p = 0.02).

7 ar whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney

8 yndrome, were randomly assigned to radial or femoral access for coronary angiography and percutaneous

9 eived Mynx devices after PCI procedures with femoral access from January 1, 2011, to September 30, 20

10 Baseline risk was higher in the femoral access group.

11 erence in treatment times between radial and femoral access in the tercile of hospitals that used rad

12 clinical characteristics between radial and femoral access procedures.

13 sedation (from 1.6% to 5.1%) and increase in femoral access using percutaneous techniques (66.8% in 2

14 (single or bifemoral or combined radial and femoral access).

15 slightly longer with radial access than with femoral access, although the 3 minute difference is unli

16 ite the common opinion that it is safer than femoral access, it has the potential for serious complic

17 Compared to femoral access, radial access is associated with greater

18 to establish noninferiority of radial versus femoral access.

19 st or head did not differ between radial and femoral access.

20 ll, 47% of patients underwent radial and 53% femoral access.

21 es in patients undergoing RA using radial or femoral access.

22 iated with treatment assignment to radial or femoral access.

23 and access site complications, compared with femoral access.

24 ; 95% CI, 0.01-0.38; P=0.004), compared with femoral access.

25 and DAP were higher with radial compared to femoral access: 10 min versus 9 min (p < 0.0001) and 65

26 eration as tissue engineered periosteum in a femoral allograft mouse model similar to fresh passaged

27 ion, diabetes, and age) to 0.719 when adding femoral and carotid plaques (p < 0.001).

28 ized blood vessel sizes were observed in the femoral and external iliac arteries but not the brachial

29 es leading to reduction of the space between femoral and ischial bones independent of gender.

30 peripheral artery disease of the superficial femoral and popliteal arteries.

31 chemic rest pain attributable to superficial femoral and popliteal peripheral artery disease were ran

32 er limb (including superficial femoral, deep femoral and popliteal) artery models that were reconstru

33 Femoral and tibial cartilages were harvested during tota

34 o maximum length) to body mass revealed that femoral and tibiotarsal width scale with isometry, whils

35 to improve vessel patency after superficial femoral angioplasty.

36 utaneous coronary intervention (PCI) via the femoral approach over a validated bleeding risk score (B

37 n bleeding events after elective PCI via the femoral approach over a validated risk score of clinical

38 800 patients undergoing elective PCI via the femoral approach were included.

39 planted in 91% of patients, via radial (7%), femoral arterial (52%), femoral venous (33%), and apical

40 t of vascular closure devices (VCDs) via the femoral arterial access site on short-term mortality in

41 tensor exercise (KE VO2 max , direct Fick by femoral arterial and venous blood samples and Doppler ul

42 re anaesthetized and ABP was monitored via a femoral arterial catheter.

43 er, we determined ex vivo fetal cerebral and femoral arterial function.

44 but did not reduce the pressor responses to femoral arterial injection of compounds that stimulate t

45 n of FAK on vascular remodeling in the mouse femoral arterial ligation (FAL) model.

46 ly associated with common carotid, brachial, femoral arterial parameters (lumen diameter [LD], wall l

47 The association between femoral arterial vascular access site management (manual

48 osis in vitro and ex vivo on porcine aortic, femoral arterial, and liver sinusoidal endothelial cells

49 Plaques were most common in femoral arteries (54%), followed by coronary calcificati

50 had no effect on the EPR in rats with patent femoral arteries (n = 9).

51 tal stump of one of the bilaterally occluded femoral arteries and the accompanying vein.

52 as the presence of any plaque in carotid or femoral arteries and/or CACS >/=1.

53 lculate the endovascular distances from both femoral arteries at the level of the upper border of the

54 The potential value of femoral arteries for improving the predictive capacity o

55 In contrast, femoral arteries from HA fetuses showed decreased contra

56 on Scientific, MA) after implantation in the femoral arteries of 18 familial hypercholesterolemic swi

57 methyl-l-arginine acetate (l-NMMA) into both femoral arteries reversed the insulin-stimulated increas

58 e, the hindlimb muscles of rats with ligated femoral arteries show increased levels of reactive oxyge

59 Injured femoral arteries showed a 20% increase in neointimal hyp

60 osclerosis with risk factors was stronger in femoral arteries than carotid or coronary arteries.

61 ater in DRG neurons isolated from rats whose femoral arteries were ligated for 72 h.

62 nd 97.9% of CT scans from the right and left femoral arteries, respectively.

63 on on the pressor reflex in rats with patent femoral arteries.

64 ygen species production in rats with ligated femoral arteries.

65 ovine model by implanting the scaffolds into femoral arteries.

66 47) in participants with completely occluded femoral arteries.

67 s from rats with freely perfused and ligated femoral arteries: peripheral artery disease (PAD) model.

68 The rabbits were euthanized, and the injured femoral artery (IF) and sham-operated femoral artery (SF

69 njured femoral artery (IF) and sham-operated femoral artery (SF) were collected for immunohistochemis

70 for TAVR in patients who were ineligible for femoral artery access and had high or prohibitive risk o

71 h rat underwent catheterization of the right femoral artery and left femoral vein.

72 y artery are anastomosed peripherally to the femoral artery and vein of the recipient, respectively.

73 mb ischemic muscle one day after ligation of femoral artery and vein.

74 nderwent endothelial denudation of the right femoral artery by air desiccation to induce an atheroscl

75 Eight 50 kg Yorkshire swine with a femoral artery catheter for blood pressure measurement a

76 new options for the treatment of superficial femoral artery disease; however, the comparative efficac

77 In some, we simulated PAD by ligating a femoral artery for 72 h before the experiment.

78 e hundred nineteen patients with superficial femoral artery in-stent restenosis and chronic limb isch

79 n pediatric cardiac interventions and avoids femoral artery injury in small infants.

80 Atherosclerosis in the superficial femoral artery is common in patients suffering from peri

81 Treatment of de novo superficial femoral artery lesions with PEB angioplasty and stenting

82 trong reduction of blood flow recovery after femoral artery ligation (arteriogenesis) dependent on th

83 iments in preclinical PAD models (unilateral femoral artery ligation and resection) were conducted to

84 ery was fully restored in 2 to 3 weeks after femoral artery ligation in all groups of mice fed a norm

85 Blood flow recovery after femoral artery ligation is significantly improved in Glr

86 od flow and failure to recover in the murine femoral artery ligation model of hindlimb ischemia.

87 nonatherosclerotic conditions, we performed femoral artery ligation surgery in mice lacking the 9p21

88 Recovery of blood flow after femoral artery ligation was impaired (>80%) in AMPKalpha

89 METHODS AND Recovery of blood flow after femoral artery ligation was impaired (>80%) in AMPKalpha

90 KEY POINTS: Ligating the femoral artery of a rat for 72 h, a model for peripheral

91 limb muscle survival and stroke volume after femoral artery or middle cerebral artery ligation, respe

92 valuate Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions With A Novel Paclita

93 Femoral artery reactivity was determined by wire myograp

94 al artery disease due to de novo superficial femoral artery stenotic or occlusive lesions were random

95 eceptor (AR) in the calcified media of human femoral artery tissue and calcified human valves.

96 n leg vascular conductance) was evaluated by femoral artery tyramine infusion.

97 After 12 weeks of an HFD, the femoral artery was ligated and blood flow recovery was m

98 (90.6%) and dissection (5.2%) of the common femoral artery with high rates of primary treatment succ

99 as administered intraarterially (ipsilateral femoral artery) or systemically to 8 CD IGS rats just be

100 APP did not alter thrombus formation in the femoral artery.

101 db/+ and db/db mice by ligation of the left femoral artery.

102 n and underwent a sham operation on the left femoral artery.

103 rmation and repair after acute injury to the femoral artery.

104 al hindlimb ischemia was induced by ligating femoral artery.

105 el and a neointimal hyperplasia model of the femoral artery.

106 sorbable following implantation in a porcine femoral artery.

107 semi-quantitative ultrasound grading of knee femoral articular cartilage, osteophytes and meniscal ex

108 ed rank test p=0.08), increased postprandial femoral ATBF (2.4 [1.6-4.0] to 6.9 [3.4-8.7], p=0.046),

109 Hypercortisolaemia increased fasting femoral ATBF (time-averaged area under the curve, from a

110 Abdominal and femoral ATBF were studied in vivo by use of the radioact

111 etween fasting or postprandial abdominal and femoral ATBF.

112 ild increase in both cerebral blood flow and femoral blood flow (P<0.05 versus normoxia) with further

113 ng parallel measurement of fetal carotid and femoral blood flow and oxygen and glucose delivery durin

114 rther, more pronounced increases observed in femoral blood flow during exercise (P<0.05 versus rest)

115 flow) and constant infusion thermodilution (femoral blood flow) with net exchange calculated via the

116 patial resolution for assessment of proximal femoral BMD.

117 Femoral bone and Rectus femoris Volumes (RFVOL) were det

118 sue microarray (TMA) analysis to a sample of femoral bone specimens from 20 exhumed individuals of kn

119 Femoral bones were harvested for strength testing, micro

120 l acquisition from the skull to the proximal femoral bones, tube voltage - 120 kVp, current tube time

121 w atypical locations such as inguinal canal, femoral canal, subhepatic, retrocecal, intraperitoneal a

122 phytes, medial meniscal extrusion and medial femoral cartilage morphological degeneration.

123 agulation results (64.5% vs 44.4%; P = .03), femoral catheters (16.1% vs 5.5%; P = .02), repair and/o

124 agulation results (49.3% vs 35.7%; P = .02), femoral catheters (9.6% vs 3.9%; P = .03), repair and/or

125 etal sheep were catheterized with aortic and femoral catheters and a flow transducer around the exter

126 tically more active, hypoxemic, and acidotic femoral circulation (P<0.05 versus cerebral).

127 tion gradients across the human cerebral and femoral circulation at rest and during exercise, an idea

128 to the fetal carotid, relative to the fetal femoral circulation, increased during and shortly after

129 ement of blood flow in the fetal carotid and femoral circulations by ultrasonic transducers has permi

130 Medial femoral condyle flaps were elevated in 18 pigs.

131 femoral condyle, two occurred in the lateral femoral condyle, and one occurred in the medial trochlea

132 BMLs on the lateral and medial femoral condyle, lateral and medial aspect of the tibial

133 Seventeen lesions occurred in the medial femoral condyle, two occurred in the lateral femoral con

134 mples were obtained from the central lateral femoral condyles in 11 patients undergoing total knee re

135 Biopsies of proximal femoral cortical bone adjacent to the fracture site were

136 Neither Folfiri nor ACVR2B/Fc had effects on femoral cortical bone, as shown by unchanged cortical bo

137 osphonate-treated cases were investigated in femoral cortices.

138 BMCs immediately after both carotid wire and femoral cuff injury were induced in order to identify ho

139 nstitution reduced neointima formation after femoral cuff injury whereas hPBMCs promoted neointima fo

140 d on seven lower limb (including superficial femoral, deep femoral and popliteal) artery models that

141 d between 2 cooling strategies: endovascular femoral devices (Icy catheter, Coolgard, Zoll, formerly

142 to 10.9 +/- 1.0% (P < 0.01) and superficial femoral dynamic arterial compliance from 0.06 +/- 0.01 t

143 ed by three point bent testing revealed that femoral elasticity and strength significantly decreased

144 techniques such as iliac stenting and common femoral endarterectomy are commonly used to reduce opera

145 ents with Blount disease and slipped capital femoral epiphyses.

146 Slipped capital femoral epiphysis (SCFE), a fracture through the physis

147 ndings also highlight the major influence on femoral failure load, particularly in the trochanteric r

148 ic diseases, whereas lower-body (gluteal and femoral) fat may be protective.

149 ndronate-to-alendronate groups) and atypical femoral fracture (2 events and 4 events, respectively) w

150 One atypical femoral fracture occurred in each group during the exten

151 ese drugs have been associated with atypical femoral fractures (AFFs), rare fractures with a transver

152 Proximal femoral fractures are a major public health concern with

153 ents, osteonecrosis of the jaw, and atypical femoral fractures were adjudicated.

154 ality was 2.2% in the radial and 2.3% in the femoral group (P=0.76).

155 was 27 minutes (25th%-75th%, 21-34) for the femoral group and 30 minutes (25th%-75th %, 24-39) for t

156 o, 0.58; 95% CI, 0.33-1.03; P=0.058) and the femoral groups (odds ratio, 0.59; 95% CI, 0.37-0.93; P=0

157 R3 phosphorylation and corrects the abnormal femoral growth plate and calvaria in organ cultures from

158 we performed epigenetic profiling of murine femoral growth plates.

159 Osteonecrosis of the femoral head (ONFH) primarily results from ischemia/hypo

160 ply results in ischemic osteonecrosis of the femoral head (ONFH).

161 t in steroid-associated osteonecrosis of the femoral head (SONFH).

162 ugh radial and tibial length and biiliac and femoral head breadth show signs of responses to directio

163 A posterior displacement of the femoral head epiphysis with a physeal step was seen on t

164 n risk of fractures and osteonecrosis of the femoral head is less understood.

165 associated with impaired blood supply to the femoral head resulting in bone necrosis and collapse.

166 imarily results from ischemia/hypoxia to the femoral head, and one of the cellular manifestations is

167 d artifacts due to simulated implants in the femoral head, sternum, and spine (P = 0.01, 0.01, and 0.

168 a significant reduction of artifacts in the femoral head, sternum, and spine.

169 of the right proximal physis below the right femoral head, with a medial and posterior slip of the ri

170 ith a medial and posterior slip of the right femoral head.

171 ion, and excessive osteoclastogenesis in the femoral head.

172 Bone samples of femoral heads from five embalmed donors and five fresh-f

173 Femoral heads were collected from normal-weight or over-

174 We extracted bone cylinders from human femoral heads, simulated an injury using a drill-hole de

175 onths of training (cholecystectomy, inguinal/femoral hernia repair, appendectomy, ventral hernia repa

176 ivery, appendectomy, and groin (inguinal and femoral) hernia repair--to quantify the potential risks

177 Thirty infants with distal femoral histologic material were identified.

178 ree sites (subclavian, internal jugular, and femoral) in adult ICU patients.

179 In contrast, renal sinus and femoral intermuscular fats were not differentially alter

180 for carotid arterial compliance, superficial femoral intima media thickness or endothelium-independen

181 3 weeks, thrombus within 3 cm of the sapheno-femoral junction, indication for full-dose anticoagulati

182 In addition, femoral length and cortical diameter and wall thickness

183 e inflammation and have increased lean mass, femoral length, and bone volume.

184 lates strongly with CVRFs, especially at the femoral level, and reflects estimated cardiovascular ris

185 trasound performed best in the assessment of femoral medial and lateral osteophytes, and medial menis

186 lls in lumbar motor roots, as well as in the femoral motor and sciatic nerves.

187 time at multiple anatomical sites, including femoral neck (-0.08%/year per one interquartile increase

188 Mean BMD of the femoral neck (0.88 g/cm2; 95% CI, 0.84-0.91 g/cm2 vs 0.9

189 For the femoral neck (18 RCTs, n = 1604), isoflavone treatment s

190 o 0.04 (P < 0.00001; 95% CI: 0.02, 0.05) and femoral neck (4 RCTs, n = 524) to 0.03 (P < 0.05; 95% CI

191 including 206 women and men with extreme low femoral neck (FN) BMD.

192 0%; n = 5) but no effect on total hip (TH), femoral neck (FN), or total body BMD or bone biomarkers.

193 bone mineral density at total femur (TFBMD), femoral neck (FNBMD), lumbar spine (LSBMD), and physicia

194 consortium for lumbar spine (n = 31,800) and femoral neck (n = 32,961) BMD, and from the arcOGEN cons

195 the L2-L4 lumbar spine vertebra (P < 0.05), femoral neck (P < 0.01), and trochanter (P < 0.01) compa

196 y in the year after critical illness at both femoral neck and anterior-posterior spine sites.

197 Consistent results were seen for change in femoral neck and lumbar spine BMD and across a range of

198 ; 95% CI, 0.94-0.94 g/cm2; P = .03) and mean femoral neck BMC (4.34 g; 95% CI, 4.13-4.57 g vs 4.59 g;

199 13.38 g; 95% CI, 13.25-13.51 g; P = .03) and femoral neck BMD (0.87 g/cm2; 95% CI, 0.74-0.83 g/cm2 vs

200 The means +/- SDs of femoral neck BMD loss were -0.02 +/- 0.05 and 0.0 +/- 0.

201 letal and sexual maturity, anthropometry and femoral neck BMD Z-score to control confounding effects.

202 besity was associated with a greater loss of femoral neck BMD.

203 Similarly, changes in spine and femoral neck bone mineral contents (BMCs) were not signi

204 Similarly, femoral neck bone mineral density increased more in the

205 nd associated with a significant increase in femoral neck bone mineral density; vascular calcificatio

206 ndom-effects models for the lumbar spine and femoral neck for all studies providing isoflavones as ag

207 Eligible patients with femoral neck fracture undergoing hemiarthroplasty were r

208 s treated with a hemiarthroplasty because of femoral neck fracture.

209 or treating BMD loss at the lumbar spine and femoral neck in estrogen-deficient women.

210 Results Capsular adhesions at the anterior femoral neck were present in 12 of the 34 patients (35%)

211 ents, and capsular adhesions at the anterior femoral neck were present in 35% of patients in both gro

212 Fracture loads at the femoral neck were significantly reduced for cecal ligati

213 fidence interval, -2.18 to -1.01; P < 0.001; femoral neck, -1.20%; 95% confidence interval, -1.69 to

214 the lumbar spine, 7.4% at total hip, 7.1% at femoral neck, and 2.3% at one-third radius.

215 the lumbar spine, 9.2% at total hip, 9.0% at femoral neck, and 2.7% at the one-third radius.

216 ation between stimulant use and total femur, femoral neck, and lumbar spine bone mineral content (BMC

217 ctive protein (hsCRP) on BMD at the forearm, femoral neck, and lumbar spine.

218 ensity (BMD) at the lumbar spine, total hip, femoral neck, and one-third radius.

219 For bone mineral density T scores at the femoral neck, biomechanical CT analysis was highly corre

220 indings, including capsular adhesions at the femoral neck, obliteration of the paralabral sulcus, lab

221 D T score of -2.5 or lower at the total hip, femoral neck, or lumbar spine; and a history of fracture

222 Similar trends were observed in the hip and femoral neck.

223 s assessed by measuring force in response to femoral nerve stimulation.

224 torque (DeltaQTsingle ) evoked by electrical femoral nerve stimulation.

225 In this model, the femoral odds ratio (2.58) exceeded the carotid odds rati

226 ovo or restenotic lesions of the superficial femoral or proximal popliteal (femoropopliteal) artery.

227 east equally well in identification of tibio-femoral osteophytes, medial meniscal extrusion and media

228 ngle-chamber pacemakers implanted by using a femoral percutaneous approach.

229 Increasing femoral perfusion pressure (FPP) by moving from the supi

230 ns of interest were placed in the tibial and femoral physes.

231 fore showed a widening of the proximal right femoral physis.

232 l significance as a determinant of total and femoral plaque in men, but not in women.

233 Screening for femoral plaques may be an appealing strategy for improvi

234 e the association of subclinical carotid and femoral plaques with risk factors and coronary artery ca

235 -term durability for aortoiliac disease than femoral popliteal disease.

236 cess-site crossover (6.3% vs. 1.7%) than did femoral procedures.

237 ial access are not associated with a loss of femoral proficiency, and centers should be encouraged to

238 was not significantly associated with recent femoral proportion after risk-adjustment (odds ratio, 0.

239 Recent femoral proportion and recent femoral volume were determ

240 ion, the risk-adjusted odds ratio for recent femoral proportion was nonsignificant (odds ratio, 0.99;

241 n through the transfemoral access and center femoral proportion, the risk-adjusted odds ratio for rec

242 ip and knee prostheses, and 1 patient with a femoral prosthesis.

243 Measurements of aortic-femoral pulse wave velocity (afPWV; n = 446) and large-

244 nine ratio measure, and a measure of carotid-femoral pulse wave velocity (cf-PWV) and augmentation in

245 conveniently measured compared with carotid-femoral pulse wave velocity (cfPWV).

246 iovascular risk factors, both higher carotid-femoral pulse wave velocity (hazard ratio [HR], 1.32; 95

247 ive protein, and arterial stiffness [carotid-femoral pulse wave velocity (PWV) and carotid augmentati

248 During 2007 to 2012, we measured carotid-femoral pulse wave velocity (PWV; SphygmoCor apparatus)

249 Carotid-to-femoral pulse wave velocity (PWVc-f) was assessed at bas

250 Arterial stiffness (carotid to femoral pulse wave velocity [PWV]) was measured and peri

251 carotid artery wall echodensity and carotid-femoral pulse wave velocity demonstrated no significant

252 nge in the weight-loss group, but carotid-to-femoral pulse wave velocity tended to decrease by 0.5 m/

253 :599-608) present repeated measures of aorto-femoral pulse wave velocity, capacitive compliance (C1),

254 troglycerin-mediated dilation (NMD), carotid-femoral pulse wave velocity, carotid-radial pulse wave v

255 hat arterial stiffness, measured via carotid-femoral pulse wave velocity, has a better predictive val

256 differences between treatment in carotid-to-femoral pulse wave velocity, high-sensitivity C-reactive

257 Aortic stiffening, assessed by carotid-femoral pulse wave velocity, is associated with CKD.

258 The mean +/- SD carotid-femoral pulse wave velocity, which reflects central aort

259 Brachial artery FMD, carotid-femoral PWV, central AIx, and blood pressure (BP) were m

260 = 61%), and lower for internal jugular than femoral (relative risk, 0.55 [95% CI, 0.34-0.89]; I = 61

261 risk, 2.25 [95% CI, 1.84-2.75]; I = 0%) and femoral (relative risk, 2.92 [95% CI, 2.11-4.04]; I = 24

262 In WT mice, the increase in femoral relaxation between 12 and 16 weeks was due to en

263 familial hypercholesterolemic swine model of femoral restenosis, the implantation of an FP-PES result

264 familial hypercholesterolemic swine model of femoral restenosis.

265 ce on catheter-related bloodstream infection femoral risk, compared with the other sites, is inconclu

266 In addition, the adduction and femoral rotation increased internally at the heel strike

267 dipose tissue from the abdominal (scABD) and femoral (scFEM) depots using an 8-week incorporation of

268 ificantly optimizes osteogenesis in a rodent femoral segmental defect model by minimizing the formati

269 njury who underwent definitive fixation of a femoral shaft fracture at a level I or II trauma center

270 rug-induced osteonecrosis and only 1 case of femoral shaft fracture in each group.

271 Femoral shaft fractures are common in major trauma.

272 iability was observed in delayed fixation of femoral shaft fractures, which could not be explained by

273 ted in relation to a reference region in the femoral shaft, which represented the bone tracer uptake

274 measured direct FFA storage in abdominal and femoral subcutaneous fat in 10 and 11 adults, respective

275 Bilateral carotid and femoral territories were explored by 3DVUS to determine

276 antifies higher plaque burden in men, in the femoral territory, and with increasing age during midlif

277 sk factors and positive CACS was stronger in femoral than carotid arteries.

278 internal jugular and subclavian, higher for femoral than subclavian (relative risk, 2.44 [95% CI, 1.

279 lipidemia were more strongly associated with femoral than with carotid disease burden, whereas hypert

280 e lacking ACVR2A had significantly increased femoral trabecular bone volume at 6 weeks of age.

281 Femoral tract length and volume are larger in taller gir

282 Results Femoral tract volume and length increased and then decre

283 decreased with age (P < .001); the peaks of femoral tract volume are consistent with the growth spur

284 Femoral translation increased anteriorly and distally at

285 0 to 59 years of age), underwent carotid and femoral ultrasound plus noncontrast coronary computed to

286 cardiac perforation, device dislocation, and femoral vascular access site complications.

287 RIPC to the femoral vascular bundle was compared against direct isch

288 ons in heart rate and exaggerated changes in femoral vascular conductance and mean arterial blood pre

289 lood samples from the coronary sinus and the femoral vein were collected at those time points and the

290 ization of the right femoral artery and left femoral vein.

291 er risk of pneumothorax than jugular-vein or femoral-vein catheterization.

292 the brachial artery and internal jugular and femoral veins with plasma and RBC nitric oxide metabolit

293 ers inserted in the brachial artery and both femoral veins.

294 ts, via radial (7%), femoral arterial (52%), femoral venous (33%), and apical (7%) approaches.

295 d (1:1) to the IASD versus a sham procedure (femoral venous access with intracardiac echocardiography

296 onary sinus was cannulated via subclavian or femoral venous approaches, and aspiration was done direc

297 ere simultaneously subjected to a unilateral femoral vessel ligation.

298 ncrease in proportion), and similarly recent femoral volume (per 100 procedures) was not found to be

299 Recent femoral proportion and recent femoral volume were determined, and in-hospital vascular

300 ed twenty-two RA cases (3069 radial and 5553 femoral) were included in the analysis.